Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.63)
# 815
Out of 4,974 analysts
134
Total ratings
54.96%
Success rate
4.12%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CHE Chemed | Maintains: Outperform | $650 → $580 | $465.63 | +24.56% | 13 | Jul 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $400 → $325 | $315.39 | +3.05% | 17 | Jul 30, 2025 | |
| CNC Centene | Maintains: Outperform | $51 → $43 | $28.98 | +48.38% | 19 | Jul 28, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $307.92 | +0.68% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $305.31 | +22.83% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $7.82 | +53.45% | 11 | Jan 24, 2025 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $24.27 | +52.45% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $420.77 | -4.94% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $173.99 | -3.44% | 8 | Oct 25, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $113.22 | +28.07% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $11.17 | +258.10% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $2.92 | +71.23% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $7.79 | - | 2 | Mar 7, 2024 |
Chemed
Jul 31, 2025
Maintains: Outperform
Price Target: $650 → $580
Current: $465.63
Upside: +24.56%
UnitedHealth Group
Jul 30, 2025
Maintains: Outperform
Price Target: $400 → $325
Current: $315.39
Upside: +3.05%
Centene
Jul 28, 2025
Maintains: Outperform
Price Target: $51 → $43
Current: $28.98
Upside: +48.38%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $307.92
Upside: +0.68%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $305.31
Upside: +22.83%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $7.82
Upside: +53.45%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $24.27
Upside: +52.45%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $420.77
Upside: -4.94%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $173.99
Upside: -3.44%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $113.22
Upside: +28.07%
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $11.17
Upside: +258.10%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $2.92
Upside: +71.23%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $7.79
Upside: -